Public policy plays a critical role. As an organization, we inform elected leaders, the news media and the constituents and audiences they serve regarding the important direct and indirect contributions these companies and their employees make to the health and economic security of this country. The biopharmaceutical industry’s unprecedented response to the COVID-19 pandemic has underscored the capacity to not only protect population health, but also to speed economic recovery.

Key public policy goals include:

• Fostering an environment for robust economic development and continuous creation of well-paying jobs with good benefits;
• Leading the world in the research and development of new cures, treatments and vaccines, improving the quality of life for all people;
• Ensuring that everyone has access to the products and services that can protect their health and improve their quality of life;
• Believe everyone should have access to products and services that can improve their health and quality of life; and
• Investing in our communities and engaging in service efforts that strengthen our futures and bring health equity to the disadvantaged and underserved.